*ST萬方(000638.SZ):放棄萬方百奧增資優先認購權、持股將降至25%
格隆匯9月22日丨*ST萬方(000638.SZ)公佈,為滿足公司控股子公司吉林萬方百奧生物科技有限公司(“萬方百奧”)的發展需求,公司與吉林百奧肽克生物科技合夥企業(有限合夥)(“百奧肽克”)、寧波麗辛投資合夥企業(有限合夥)(“寧波麗辛”)、北京華陽眾創科技有限公司(“華陽眾創”)、潤田之光(北京)農業科技有限公司(“潤田之光”)簽訂《吉林萬方百奧生物科技有限公司股東增資協議》,根據增資協議規定,寧波麗辛、華陽眾創、潤田之光將以2元/股的價格分別向萬方百奧增資3600萬元、2600萬元和9300萬元,對應增加萬方百奧註冊資本1800萬元、1300萬元和4650萬元,公司放棄此次增資優先認購權。
此次交易完成後,萬方百奧的註冊資本由7450萬元增加至15200萬元,公司對萬方百奧的持股比例由51.0067%變為25%,公司將不再是萬方百奧的第一大股東,萬方百奧將不再納入公司合併報表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.